title: Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples.
abstract: OBJECTIVE
  To systematically review cost of illness studies for schizophrenia (SC), epilepsy (EP) and type 2 diabetes mellitus (T2DM) and explore the transferability of direct medical cost across countries.
  
  
  METHODS
  A comprehensive literature search was performed to yield studies that estimated direct medical costs. A generalized linear model (GLM) with gamma distribution and log link was utilized to explore the variation in costs that accounted by the included factors. Both parametric (Random-effects model) and non-parametric (Boot-strapping) meta-analyses were performed to pool the converted raw cost data (expressed as percentage of GDP/capita of the country where the study was conducted).
  
  
  RESULTS
  In total, 93 articles were included (40 studies were for T2DM, 34 studies for EP and 19 studies for SC). Significant variances were detected inter- and intra-disease classes for the direct medical costs. Multivariate analysis identified that GDP/capita (p<0.05) was a significant factor contributing to the large variance in the cost results. Bootstrapping meta-analysis generated more conservative estimations with slightly wider 95% confidence intervals (CI) than the parametric meta-analysis, yielding a mean (95%CI) of 16.43% (11.32, 21.54) for T2DM, 36.17% (22.34, 50.00) for SC and 10.49% (7.86, 13.41) for EP.
  
  
  CONCLUSIONS
  Converting the raw cost data into percentage of GDP/capita of individual country was demonstrated to be a feasible approach to transfer the direct medical cost across countries. The approach from our study to obtain an estimated direct cost value along with the size of specific disease population from each jurisdiction could be used for a quick check on the economic burden of particular disease for countries without such data.
authors.affiliation: School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
authors.forename: Lan
authors.initials: L
authors.lastname: Gao
authors.affiliation: School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
authors.forename: Hao
authors.initials: H
authors.lastname: Hu
authors.affiliation: Access and Public Affair, Pfizer Australia, West Ryde, NSW, Australia.
authors.forename: Fei-Li
authors.initials: FL
authors.lastname: Zhao
authors.affiliation: School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
authors.forename: Shu-Chuen
authors.initials: SC
authors.lastname: Li
mesh_terms: D002908:Chronic Disease; D017281:Cost of Illness; D003924:Diabetes Mellitus, Type 2 / Q000191:economics*; D004827:Epilepsy / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D018803:Models, Economic; D012559:Schizophrenia / Q000191:economics*
references.citation: Epilepsia. 2009 Oct;50(10):2186-91
references.pmid: 19508694
references.citation: Value Health. 2009 Sep;12(6):923-9
references.pmid: 19824187
references.citation: Diabetes Res Clin Pract. 2010 Sep;89(3):334-40
references.pmid: 20538363
references.citation: Psychiatry Clin Neurosci. 2003 Aug;57(4):373-7
references.pmid: 12839517
references.citation: Epilepsia. 1997 Nov;38(11):1221-6
references.pmid: 9579924
references.citation: Health Policy. 2010 May;95(2-3):271-6
references.pmid: 20061044
references.citation: Epilepsy Res. 2002 Feb;48(3):207-16
references.pmid: 11904239
references.citation: Epilepsy Res. 2003 May;54(2-3):131-40
references.pmid: 12837564
references.citation: Med Care. 2012 Nov;50(11):928-33
references.pmid: 23047781
references.citation: Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62
references.pmid: 6923138
references.citation: Curr Med Res Opin. 2007 Apr;23(4):671-82
references.pmid: 17407623
references.citation: Diabet Med. 2012 Jul;29(7):855-62
references.pmid: 22537247
references.citation: Seizure. 2005 Jan;14(1):46-51
references.pmid: 15642500
references.citation: Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):302-9
references.pmid: 15216447
references.citation: Curr Med Res Opin. 2005 Dec;21(12):2017-28
references.pmid: 16368053
references.citation: J Intern Med. 2001 Jul;250(1):57-65
references.pmid: 11454143
references.citation: BMC Endocr Disord. 2010 Sep 20;10:15
references.pmid: 20854689
references.citation: Seizure. 2003 Dec;12(8):555-60
references.pmid: 14630493
references.citation: Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):579-95
references.pmid: 24138645
references.citation: Pharmacoeconomics. 1999 Jun;15(6):597-610
references.pmid: 10538332
references.citation: Health Policy. 2000 Feb;51(1):1-18
references.pmid: 11010222
references.citation: PLoS One. 2011;6(10):e26864
references.pmid: 22066013
references.citation: Diabetes Care. 2013 Apr;36(4):1033-46
references.pmid: 23468086
references.citation: Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):684-90
references.pmid: 21907553
references.citation: J Korean Med Sci. 2008 Apr;23(2):167-75
references.pmid: 18436996
references.citation: Pharmacoeconomics. 1997 Jun;11(6):578-94
references.pmid: 10168096
references.citation: Aust N Z J Psychiatry. 2007 Oct;41(10):819-29
references.pmid: 17828655
references.citation: Rev Panam Salud Publica. 2009 Jul;26(1):55-63
references.pmid: 19814883
references.citation: Epilepsia. 2006 Dec;47(12):2165-72
references.pmid: 17201718
references.citation: Acta Psychiatr Scand. 2005 Jul;112(1):54-63
references.pmid: 15952946
references.citation: Diabetes Care. 2007 Feb;30(2):252-6
references.pmid: 17259490
references.citation: Curr Med Res Opin. 2010 Apr;26(4):943-55
references.pmid: 20163295
references.citation: Pharmacoeconomics. 2000 Feb;17(2):197-208
references.pmid: 10947342
references.citation: Psychiatr Serv. 2004 Aug;55(8):928-30
references.pmid: 15292543
references.citation: Epilepsy Res. 1994 Jul;18(3):249-60
references.pmid: 7805646
references.citation: Diabetes Care. 2009 Dec;32(12):2187-92
references.pmid: 19729528
references.citation: Epilepsy Res. 2013 Feb;103(2-3):288-93
references.pmid: 22858375
references.citation: Neuroepidemiology. 2000 Mar-Apr;19(2):87-99
references.pmid: 10686533
references.citation: Health Aff (Millwood). 2010 Feb;29(2):297-303
references.pmid: 20075080
references.citation: Clinicoecon Outcomes Res. 2011;3:89-104
references.pmid: 21935337
references.citation: Epilepsia. 1999 Mar;40(3):351-8
references.pmid: 10080518
references.citation: Ir Med J. 2006 Nov-Dec;99(10):307-10
references.pmid: 17274175
references.citation: BMC Health Serv Res. 2007;7:189
references.pmid: 18028552
references.citation: Epilepsy Res. 2008 Oct;81(2-3):176-87
references.pmid: 18617369
references.citation: J Ment Health Policy Econ. 2005 Sep;8(3):153-65
references.pmid: 16278503
references.citation: Diabetologia. 2009 Aug;52(8):1520-7
references.pmid: 19475364
references.citation: J Clin Psychiatry. 2005 Sep;66(9):1122-9
references.pmid: 16187769
references.citation: J Ment Health Policy Econ. 2007 Mar;10(1):23-41
references.pmid: 17417045
references.citation: Seizure. 2000 Mar;9(2):88-95
references.pmid: 10845731
references.citation: Pharmacoeconomics. 2013 Jun;31(6):501-8
references.pmid: 23620212
references.citation: Epilepsia. 2004 Feb;45(2):171-8
references.pmid: 14738425
references.citation: Value Health. 2010 Dec;13(8):1028-37
references.pmid: 20667054
references.citation: Value Health. 2001 May-Jun;4(3):251-7
references.pmid: 11705186
references.citation: Bull World Health Organ. 2003;81(1):19-27
references.pmid: 12640472
references.citation: Epilepsy Res. 2001 Dec;47(3):205-15
references.pmid: 11738928
references.citation: Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):661-84
references.pmid: 25047664
references.citation: Psychiatry Res. 2008 Apr 15;158(3):306-15
references.pmid: 18243334
references.citation: Can J Psychiatry. 1999 Jun;44(5):464-72
references.pmid: 10389607
references.citation: Diabetes Care. 2004 Nov;27(11):2616-21
references.pmid: 15504995
references.citation: Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192
references.pmid: 15544708
references.citation: Value Health. 2007 Jul-Aug;10(4):223-30
references.pmid: 17645676
references.citation: Health Serv Res. 2009 Feb;44(1):303-20
references.pmid: 19146569
references.citation: Treat Endocrinol. 2003;2(2):121-33
references.pmid: 15871548
references.citation: Pharmacoeconomics. 2004;22(13):857-76
references.pmid: 15329031
references.citation: Health Soc Care Community. 2011 May;19(3):289-98
references.pmid: 21276105
references.citation: Pharmacoeconomics. 1998 Dec;14(6):671-84
references.pmid: 10346418
references.citation: Epilepsia. 2001 Aug;42(8):1052-60
references.pmid: 11554893
references.citation: Eur J Public Health. 2004 Mar;14(1):3-9
references.pmid: 15080382
references.citation: Diabetes Care. 1996 Dec;19(12):1416-9
references.pmid: 8941474
references.citation: Epilepsia. 1994 Nov-Dec;35(6):1230-43
references.pmid: 7988516
references.citation: Int J Technol Assess Health Care. 2001 Spring;17(2):155-63
references.pmid: 11446127
references.citation: Epilepsia. 2011 May;52(5):949-56
references.pmid: 21275976
references.citation: Epilepsia. 1998 Jul;39(7):776-86
references.pmid: 9670907
references.citation: J Occup Environ Med. 2009 Dec;51(12):1460-5
references.pmid: 19952787
references.citation: Epilepsia. 2009 Oct;50(10):2192-8
references.pmid: 19583782
references.citation: Neurologia. 2011 Jan-Feb;26(1):32-8
references.pmid: 21163205
references.citation: Diabetes Metab J. 2011 Dec;35(6):567-70
references.pmid: 22247897
references.citation: Clin Mol Hepatol. 2014 Dec;20(4):327-37
references.pmid: 25548737
references.citation: Pharmacoeconomics. 2011 Aug;29(8):653-71
references.pmid: 21604822
references.citation: Int J Cardiol. 2013 May 10;165(2):273-7
references.pmid: 21908062
references.citation: Value Health. 2002 Sep-Oct;5(5):398-404
references.pmid: 12201857
references.citation: J Ment Health Policy Econ. 2012 Mar;15(1):25-32
references.pmid: 22611090
references.citation: Schizophr Bull. 2004;30(2):295-302
references.pmid: 15279047
references.citation: Health Policy. 2006 Jun;77(1):51-63
references.pmid: 16139925
references.citation: Epilepsia. 2004 Mar;45(3):289-91
references.pmid: 15009233
references.citation: Value Health. 2011 Jul-Aug;14(5 Suppl 1):S137-40
references.pmid: 21839888
references.citation: Epilepsia. 2000 Mar;41(3):342-51
references.pmid: 10714408
references.citation: Epilepsy Res. 1996 Mar;23(2):139-48
references.pmid: 8964275
references.citation: Epilepsy Behav. 2012 Apr;23(4):451-7
references.pmid: 22381385
references.citation: Diabetes Care. 2003 Mar;26(3):917-32
references.pmid: 12610059
references.citation: Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):377-85
references.pmid: 21264804
references.citation: J Intern Med. 2000 Nov;248(5):387-96
references.pmid: 11123503
references.citation: Arch Med Res. 2006 Apr;37(3):376-83
references.pmid: 16513488
references.citation: Int J Clin Pharmacol Ther. 2007 Aug;45(8):455-68
references.pmid: 17725179
references.citation: Epilepsia. 2004 Jun;45(6):673-7
references.pmid: 15144433
references.citation: Seizure. 1999 Dec;8(8):456-64
references.pmid: 10627407
references.citation: Diabetes Care. 2002 Aug;25(8):1303-7
references.pmid: 12145225
references.citation: Eur J Health Econ. 2012 Dec;13(6):819-26
references.pmid: 22042322
references.citation: BMC Int Health Hum Rights. 2009 Mar 31;9:6
references.pmid: 19335903
references.citation: Aust N Z J Psychiatry. 2003 Feb;37(1):31-40
references.pmid: 12534654
references.citation: Pharmacoeconomics. 2010;28(8):675-85
references.pmid: 20623993
references.citation: Afr J Med Med Sci. 2005 Mar;34(1):15-23
references.pmid: 15971549
references.citation: Diabet Med. 2006 Mar;23(3):299-305
references.pmid: 16492214
references.citation: Seizure. 1994 Jun;3(2):115-20
references.pmid: 8081637
references.citation: J Manag Care Pharm. 2006 Sep;12(7):546-54
references.pmid: 16981800
references.citation: Diabetologia. 2006 Jul;49(7):1498-504
references.pmid: 16752168